Akers Biosciences Reports Q2 2019 Earnings
15. August 2019 09:00 ET
|
Akers Biosciences Inc.
Continued Progress Toward Positioning the Company for Strategic Alternatives THOROFARE, N.J., Aug. 15, 2019 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (“Akers Bio” or the...
Akers Biosciences Reports Q1 2019 Earnings
20. Mai 2019 17:38 ET
|
Akers Biosciences Inc.
Continued Progress Toward Positioning the Company for Strategic Alternatives THOROFARE, N.J., May 20, 2019 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (“Akers Bio” or the...
Akers Biosciences Reports Fiscal Year 2018 Earnings
01. April 2019 17:31 ET
|
Akers Biosciences Inc.
Ongoing Measures to Streamline Operations, Reduce Costs and Position the Company for Strategic Alternatives THOROFARE, N.J., April 01, 2019 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc....
Akers Biosciences Exploring Potential Business Combinations in Alternative Sectors Including Cannabis Industry
19. November 2018 09:01 ET
|
Akers Biosciences Inc.
THOROFARE, N.J., Nov. 19, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, is...
Akers Biosciences Announces Q3 2018 Earnings
15. November 2018 07:00 ET
|
Akers Biosciences Inc.
Sales of Flagship PIFA Heparin PF/4 Rapid Assay Products Up 16% over Q3 2017; Company Continuing to Evaluate Strategic Alternatives to Maximize Shareholder Value THOROFARE, N.J., Nov. 15, 2018 ...
Akers Biosciences Announces Intention to Explore Strategic Alternatives to Maximize Shareholder Value
07. November 2018 09:15 ET
|
Akers Biosciences Inc
Announces 1:8 Reverse Stock Split THOROFARE, N.J., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid...